Ekter SA (ATH:EKTER)

Market Cap	68.41M
Revenue (ttm)	86.24M
Net Income (ttm)	10.31M
Shares Out	26.88M
EPS (ttm)	0.38
PE Ratio	6.63
Forward PE	n/a
Dividend	0.06 (2.36%)
Ex-Dividend Date	Jul 14, 2025

Volume	56,889
Average Volume	122,958
Open	2.540
Previous Close	2.545
Day's Range	2.445 - 2.550
52-Week Range	1.350 - 2.580
Beta	0.98
RSI	73.23
Earnings Date	Sep 26, 2025

About Ligand Pharmaceuticals

Ekter SA, together with its subsidiaries, operates as a construction company in Greece. It undertakes various construction projects for the public and private sectors, such as infrastructure projects, including highways, drainage networks, metro stations, and sanitary culverts for sewage systems; hospitals; airports; museums; buildings and renovations comprising warehouses, office buildings, exhibition spaces, residential buildings, embassies, courthouses, universities, and malls; hotels; medical and hotel equipment; ICU buildings; and children...

• Industry: Engineering & Construction
• Sector: Industrials
• Founded: 1959
• Employees: 96
• Stock Exchange: Athens Stock Exchange
• Ticker Symbol: EKTER

Financial Performance

In 2024, Ekter's revenue was 86.24 million, an increase of 9.06% compared to the previous year's 79.07 million. Earnings were 10.31 million, an increase of 14.89%.